Related Experiment Video
Updated: Feb 18, 2026

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
1.2K
Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability.
Zhengjun Gao1, Yiyuan Li1, Fei Wang1
1Life Sciences Institute, Zhejiang University, Hangzhou, 310058, China.
Nature Communications
|November 29, 2017
Summary
Mitochondrial morphology switching, regulated by FAM73b, enhances anti-tumor immunity by promoting IL-12 production and T-cell activation. This finding offers potential cancer immunotherapy targets.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Innate immune cells like macrophages are crucial for inflammation and host defense.
- Mitochondrial dynamics and metabolic shifts are implicated in immune responses.
- The role of mitochondrial morphology in myeloid cells' anti-tumor immunity remains largely unknown.
Purpose of the Study:
- To investigate the function of FAM73b in regulating mitochondrial morphology in immune cells.
- To determine the impact of mitochondrial morphology switching on anti-tumor immunity.
- To explore the molecular mechanisms linking mitochondrial dynamics to immune cell function.
Main Methods:
- Utilized gene ablation techniques to study FAM73b (Miga2) function.
- Analyzed mitochondrial morphology changes (fusion vs. fission).
- Assessed IL-12 production, T-cell activation, and Parkin-mediated protein degradation pathways.
Main Results:
- FAM73b regulates Toll-like receptor-mediated switching of mitochondrial morphology from fusion to fission.
- Ablation of Fam73b promotes mitochondrial fission, leading to increased IL-12 production.
- This mitochondrial switch in tumor-associated macrophages enhances T-cell activation and anti-tumor immunity.
- Mitochondrial morphology influences Parkin expression and its role in the CHIP-IRF1 axis stability.
Conclusions:
- FAM73b is a key regulator of mitochondrial dynamics in immune cells.
- Mitochondrial fission promotes IL-12 production and enhances anti-tumor immune responses.
- The identified mechanisms highlight mitochondrial dynamics as potential targets for cancer immunotherapy.
Related Concept Videos
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Mitochondrial Membranes
17.4K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.4K
Electron Transport Chain: Complex I and II
19.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.1K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K

